New Year brings New PBS listings
The first day of the new year brought with it new hope for Australians fighting one of the most common blood cancers, thanks to a critical new medicine listed on the Pharmaceutical Benefits Scheme (PBS).On 1st January 2021, Darzalex® (daratumumab) was listed for the first time in combination with bortezomib and dexamethasone, as a second-line…